LATe Cerclage in High-risk Pregnancies (LATCH)
Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
Thomas Jefferson University
329 participants
Nov 10, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Eligibility
Inclusion Criteria3
- -50 years old, pregnant, assigned female at birth
- Singleton pregnancy
- TVU CL ≤25mm between 24 0/7 - 26 6/7 weeks of gestation
Exclusion Criteria10
- Initial multifetal gestation with subsequent multifetal pregnancy reduction, or selective fetal termination performed >14 weeks, or cotwin pregnancy loss diagnosed >14 weeks
- Cerclage in situ
- Preterm labor, defined as painful regular uterine contractions and change in cervical dilation
- PPROM
- Active vaginal bleeding
- Suspected intraamniotic infection
- Major fetal structural abnormality or chromosomal disorder
- Placenta previa or accreta
- Other contraindication to cerclage placement
- Participation in another clinical trial related to preterm birth prevention, cerclage, or progesterone
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transvaginal cervical cerclage placed between 24 0/7 - 26 6/7 weeks of gestation.
Continuing or initiation of vaginal progesterone 200mg daily until 36 weeks of gestation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06036446